Why Are Psychedelics Illegal in Australia? A Guide to the Law and Its History

In Australia, psychedelics like psilocybin and MDMA are generally illegal. Nevertheless, the country recently made a historic exception. Since July 2023, authorised psychiatrists can prescribe MDMA for PTSD and psilocybin for treatment-resistant depression (TRD) under strict conditions . Consequently, understanding why psychedelics remain prohibited for all other uses requires looking at history, international treaties, and federal and state laws.

The Historical Context: From Medicine to Prohibition

The story of psychedelics is not one of simple villainy. Humans have used these substances for thousands of years . In the 1950s and 1960s, psychiatrists in Australia and worldwide used LSD to treat patients through “psycholytic psychotherapy” . However, the political and social upheaval of the 1960s, particularly the Vietnam War and the counter-culture movement, cast these drugs in a negative light . Subsequently, US President Richard Nixon’s “war on drugs” led to strict laws in America, which heavily influenced policy in Australia and elsewhere .

Why Psychedelics Remain Illegal: The Core Reasons

1. The Poisons Standard and Federal Scheduling

The primary mechanism for controlling drugs is the Poisons Standard, which schedules substances by risk . Most psychedelics like LSD, DMT, and mescaline are in Schedule 9, the strictest category. This means they are “prohibited substances” that can only be used for medical or scientific research with special approval . Even MDMA and psilocybin, the legal exceptions, remain Schedule 9 for all other indications, limiting their use to medical and scientific research . Before the 2023 change, they were entirely in Schedule 9.

2. The Unapproved Status of the Medicines

The legal pathway for MDMA and psilocybin is narrow because they are “unapproved” therapeutic goods. They are not listed on the Australian Register of Therapeutic Goods (ARTG), meaning the TGA has not assessed their safety, quality, or efficacy for general use . This status, combined with the historical stigma, means authorities consider them high-risk and restrict them to tightly controlled clinical settings.

3. The Interaction with State and Territory Laws

While the TGA schedules substances, states and territories enforce their own drug laws, creating a complex web of regulation . For a long time, these state laws blocked access even when the TGA tried to create pathways. For instance, in New South Wales, the Drug Misuse and Trafficking Act lists substances like MDMA as prohibited drugs, making therapeutic use illegal in practice . Similarly, Queensland, Victoria, and other states have their own laws criminalizing possession and supply . The 2023 reform attempted to create a national pathway, but psychiatrists still need to follow state and territory laws, which can vary .

The Strict Exceptions: Therapeutic Access in Australia

The rescheduling of MDMA and psilocybin is a controlled exception. Their use is legal only:

• For Specific Conditions: MDMA for PTSD; psilocybin for treatment-resistant depression .
• By Authorised Psychiatrists: Only psychiatrists registered with the Medical Board of Australia and the RANZCP can prescribe these substances .
• Through a Rigorous System: Psychiatrists must become Authorised Prescribers (AP), develop a clinical protocol, and receive approval from an HREC and the TGA .
• In a Controlled Setting: The treatment must occur in a medically supervised environment; patients cannot take the medicine home .

Challenges and the Future

The current framework still faces significant challenges. The scheme has been criticised for being too restrictive and expensive . Furthermore, there is disuniformity between states and territories, and concerns about the unlawful promotion of these therapies persist . As of May 2026, only 40 psychiatrists are approved, and a total of 238 patients have been treated outside of clinical trials . The TGA continues to review the rules, aiming to balance access with safety, but significant barriers remain .

Conclusion

Psychedelics are illegal in Australia due to a combination of historical stigma, a cautious regulatory framework that considers them high-risk, and complex interactions between federal and state laws. The 2023 reform created a strict and narrow legal exception for therapeutic use, but this does not change the overall legal status. For the vast majority of Australians, and for psychedelics outside the specified treatments, they remain prohibited substances with severe penalties for possession and supply.